This narrative review explores the association between helicobacter pylori and inflammatory bowel disease, highlighting infection prevalence and treatment implications.
Key Points
Significantly lower prevalence of helicobacter pylori infection is observed in inflammatory bowel disease patients compared to the general population.
Meta-analyses suggest helicobacter pylori may protect against inflammatory bowel disease, especially in crohn's disease patients.
Eradication therapy's impact on inflammatory bowel disease progression shows variability, with some studies reporting increased relapse risks.
Individualized treatment decisions regarding helicobacter pylori eradication in IBD should consider the complex relationship with gut microbiota.